Glaucoma is a neurodegenerative disease that can cause irreversible vision loss. Elevated intraocular pressure is a major risk factor for the glaucoma; however, the disease may still progress in some patients after lowering IOP. Citicoline has been suggested as a potential therapeutic to ameliorate damage caused by neurodegenerative diseases, including glaucoma, but its neuroprotective effects remain incompletely studied. In this study, we analyzed the dose-dependent effect of oral citicoline on visual behavior response and white matter integrity in a rodent model of glaucoma. The results show citicoline preserves visual behavior response and visual system integrity in a dose dependent manner.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords